Share This

Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
石藥集團新藥SYH2068注射液獲准開展臨床試驗

2025-04-27T  
國藥控股附屬國藥股份首季淨利潤微降至4.59億人民幣

2025-04-25T  
國藥控股附屬國藥一致首季淨利潤3.28億人民幣 倒退15.6%

2025-04-24T  
《業績》國藥控股附屬國藥器械首季營業利潤2.77億人幣 按年跌7.4%

2025-04-24T  
四環醫藥達格列淨片獲國家藥監局上市批准

2025-04-24T  
石藥集團附屬石藥創新第一季轉虧2,690萬人民幣

2025-04-23T  
新華製藥鹽酸美金剛口服溶液獲發藥品註冊證書

2025-04-23T  
新華製藥普瑞巴林口服溶液獲國家藥監局註冊證書

2025-04-23T  
石藥集團普盧格列汀二甲雙胍緩釋片臨床試驗獲批

2025-04-23T  
石藥集團抗體藥JMT203獲美FDA批准開展臨床研究

2025-04-22T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.